Richard Milton Ransohoff - Nanotechnology

Author Information

Richard Milton Ransohoff is a prominent researcher affiliated with Neuro/Immuno Discovery Biology at Biogen, located in Cambridge, MA, USA. His work primarily focuses on the intersections of neuroscience and immunology, particularly concerning the roles and states of microglia in the central nervous system.

Research Contributions

Richard M. Ransohoff's research contributions are extensive and largely centered around the study of microglia, the blood-brain barrier (BBB), and neurodegenerative diseases. His recent work involves defining microglial states and the impact of various genetic variants on neurogenesis and remyelination in multiple sclerosis models. Key studies include investigations into the effects of IL-6 blockade on BBB disorders, which have implications for preventing the onset of neuromyelitis optica spectrum disorders (NMOSD). He has also contributed significantly to the understanding of microglial transcriptome profiles and their association with neurodegenerative progression.

Aliases

Throughout his career, Richard Milton Ransohoff has been referred to by several aliases, including R. M. Ransohoff, R Ransohoff, R.m. Ransohoff, Richard Ransohoff, Richard\u2004m. Ransohoff, Richardm. Ransohoff, Richard M Ransohoff, and R M Ransohoff.

Publication and Citation Metrics

Total Citation Count 79,017
h-index 136
Total Papers Published 624

Publications:

DOI: 10.1016/s1471-4906(21)00186-1

Year: 2021

Partnered Content Networks

Relevant Topics